Atlas Trials

Study Assessing Risk of Autoimmune Diseases in Females (9 - 25 Years) Exposed to Cervarix® in United Kingdom

Clinical trial NCT01953822 · COMPLETED

Trial details

NCT number
NCT01953822
Sponsor
GlaxoSmithKline
Status
COMPLETED
Study type
OBSERVATIONAL
Infections, Papillomavirus
Start date
2013-10-01
Primary completion
2014-08-01
Enrollment
1053

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.